Treatment Of Myasthenia Gravis Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
IMVT | F | Immunovant, Inc. | -1.21 | |
GTBP | F | GT Biopharma, Inc. | -4.51 |
Related Industries: Biotechnology
Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Myasthenia Gravis stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
SBIO | D | ALPS Medical Breakthroughs ETF | 2.87 | |
BBC | D | Virtus LifeSci Biotech Clinical Trials ETF | 0.92 | |
BTEC | C | Principal Healthcare Innovators Index ETF | 0.82 | |
XBI | C | SPDR S&P Biotech ETF | 0.54 | |
NSCS | C | Nuveen Small Cap Select ETF | 0.43 |
Compare ETFs
Related Industries:
Biotechnology
- Treatment Of Myasthenia Gravis
Treatment of myasthenia gravis typically involves medications, such as cholinesterase inhibitors, immunosuppressants, and corticosteroids, as well as other therapies, such as plasmapheresis and thymectomy. The goal of treatment is to reduce the severity of symptoms and improve the patient's quality of life.
Recent Comments
- TraderMike on Bollinger Band Squeeze
- TraderMike on Bollinger Band Squeeze
- OpenCat584 on Bollinger Band Squeeze
- Dr_Duru on Expansion Breakout
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
From the Blog
Featured Articles